Patents by Inventor Carter Graham

Carter Graham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified kertinocyte growth factor (kgf) with reduced immunogenicity
    Publication number: 20040063634
    Abstract: The present invention relates to polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptides are modified polypeptides whereby the modification results in a reduced propensity for the polypeptide to elicit an immune response upon administration to the human subject. The invention in particular relates to the modification of keratinocyte growth factor (KGF) to result in keratinocyte growth factor (KGF) proteins that are substantially non-immunogenic or less immunogenic than any non-modified counterpart when used in vivo.
    Type: Application
    Filed: August 5, 2003
    Publication date: April 1, 2004
    Inventors: Francis J. Carr, Carter Graham, Tim Jones, Stephen Williams
  • Modified erythropoietin (epo) with reduced immunogenicity
    Publication number: 20040063917
    Abstract: The present invention relates to polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptides are modified polypeptides whereby the modification results in a reduced propensity for the polypeptide to elicit an immune response upon administration to the human subject. The inention in particular relates to the modification of erythropoietin (EPO) to result in erythropoietin proteins that are substantially non-immunogenic or less immunogenic than any non-modified counterpart when used in vivo.
    Type: Application
    Filed: August 5, 2003
    Publication date: April 1, 2004
    Inventors: Francis J. Carr, Carter Graham, Tim Jones, Stephen Williams